From Science 2.0 to Pharma 3.0

Semantic Search and Social Media in the Pharmaceutical industry and STM Publishing


  • Hervé Basset, Science Intelligence, France
  • David Stuart, King's College London, UK
  • Denise Silber, BASIL Strategies & Doctors 2.0 TM & You, France

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of ‘3.0’ in Pharma and STM publishing.
View full description


Those interested in Science 2.0 and Pharma 3.0., including researchers, information professionals, and managers


Book information

  • Published: September 2012
  • Imprint: Chandos Publishing
  • ISBN: 978-1-84334-709-5


I can only highly recommend reading this book by Hervé Basset for a better understanding of the challenges of social media., Jean-Philippe Accart
I was impressed by the team of authors who worked on the book. Their knowledge of the subject and understanding of the respective industries, as well as the level of control of vast literature and information is very impressive., Information Research
As a librarian in a large pharmaceutical company, Hervé Bassett has a perspective both on drug manufacturers and consumers of scientific information., Information Today

Table of Contents

Part 1 From science 2.0 (2000-2010); The web 2.0 revolution, and the promise of science 2.0: The web as a platform: Web services, the cloud, and the app; The network as a science platform; Harnessing collective intelligence; Collective science; Data as the ‘next Intel Inside’; Open science data; The state of Science 2.0; A reluctance to change; Scepticism and the promise of Science 2.0; The lack of a supportive environment. Part 2 To Pharma 2.0: Health 2.0 and beyond: 2.0 becomes Social Media; Big promises: Is there gold? Leading health 2.0 and social media sites and applications; The digital Pharma: The pharma industry adopts; Social attempts; 5 top stories; The digital Pharma influence; The industry watches; The industry remains cautious (the dark face of SoMe). Part 3 To Pharma 3.0 (2010-): Semantic search in Life Sciences: Semantic? What’s this? What do researchers expect; A survey of biomedical semantic interfaces; The future will be semantic; The semantic for Pharmas; Enterprise 2.0 and web 2.0: Enterprise 2.0; MS SharePoint 2010; And the next revolutions are? Next 3.0: Science 3.0; Pharma 3.0; Big STM 3.0; Conclusion.